glp 1 vision loss lawsuit GLP-1 NAION The next frontier in GLP-1

Adverse reactions and tolerability: Since they are administered via injection and affect gastric emptying (particularly in the case of shorter-acting agents), GLP-1 receptor agonists present some tolerability concerns

We accept Aetna, United Healthcare, Cigna, and Blue Cross Blue Shield

Song Y, Yang J, Chang M, Wei Y, Yin Z, Zhu Y, et al

Knauf, C

People who have been on their medication for 4 or more weeks and have stable gastrointestinal function

A new study in JAMA Oncology warns that GLP-1 receptor agonists like Ozempic and Mounjaro may raise the risk of kidney cancer, even though they seem to lower the risk of other cancers